Better understanding of wound healing could lead to improved treatment(s) of multiple sclerosis (MS) and psoriasis (Pso). New concepts in the events of wound healing, such as the roles of the innate and adaptive immune systems, have generated targets for treating these debilitating diseases. That in MS and Pso defective wound healing is responsible for the diseases' progression has not been hypothesized to date. Impaired initiation of wound repair by oligodendrocyte precursor cells or oligodendrocytes may play a role in MS, and a lack of inhibition of the proliferative phase in wound healing may explain the pathophysiology involved in Pso.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994149 | PMC |
http://dx.doi.org/10.1089/wound.2017.0773 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!